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Fixation of penicilloyl groups to albumin in penicillin-treated patients was shown to involve histidine residues 146 and 
338. 
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1. INTRODUCTION 
Transient bisalbuminemia due to the presence of 
a fast albumin component in the serum of patients 
given large doses of penicillin was first described 
by Arvan et al. [l]. Fast albumin was subsequently 
isolated by ion-exchange chromatography and the 
presence of penicilloyl groups (BP0 groups) on it 
was ascertained using RIA [2] and ELISA [3]. The 
kinetics of BP0 group fixation to albumin of 
penicillin-treated patients as well as the im- 
munological significance of this process have 
recently been reported [4]. 
Two fixation sites for BP0 groups have been 
demonstrated on the albumin molecule and found 
to be located on CNBr fragments c124-298 and 
A299_585 [5]. In the present study, identification of 
these sites was carried out on purified tryptic pep- 
tides derived from CNBr fragments of fast 
albumin from penicillin-treated patients. It was 
shown that fixation of BP0 groups involved 
histidine residues 146 and 338. 
2. MATERIALS AND METHODS 
Benzyl-penicillin sodium salt was obtained from Serva 
(France). Human serum albumin (HSA) 100% pure on elec- 
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trophoresis was obtained from Mann. Trypsin (TPCK-treated) 
from bovine pancreas was from Serva. Polyamide plates (2.5 x 
2.5 cm) were from Schleicher & Schilll. Phenylisothiocyanate 
(PITC) was purchased from Pierce. 4-N,N-Dimethylazoben- 
zene (DABITC) was obtained from Fluka. N-Bromoacetyl-L- 
tryptophan was synthesized as specified by Gambhir and 
McMenamy [6]. 
BP0 groups were determined by the enzyme-linked- 
immunosorbent assay described by Lapresle and Lafaye [3]. 
This ELISA consists of inhibiting by penicilloylated proteins 
the fixation of penicilloylated alkaline phosphatase (PAP) to 
antipenicilloyl antibodies. 
Sera were taken from four patients (FAU, GER, LEV and 
LOI) whose clinical picture was reported by Lafaye and Lapre- 
sle [4]. These patients were given intravenously 50 x lo6 IU of 
penicillin G over a 20-40-day period. Sera were collected at the 
end of each treatment and mixed. Fast albumin was prepared 
as described by Lapresle and Wal [2] using chromatography on 
DEAE-Sephadex. CNBr fragments of fast albumin were ob- 
tained according to Lapresle and Doyen [7]. Reduction and car- 
boxymethylation of CNBr-fragments were carried out 
according to Crestfield et al. [8]. 
Immunoadsorbents were prepared by reacting 1 g of CNBr- 
activted Sepharose 4B with 10 mg of purified antipenicilloyl an- 
tibodies as recommended by the manufacturer (Pharmacia). 
The fragments were digested with TPCK-trypsin (19’0, w/w) at 
37°C for 24 h in 50 mM ammonium bicarbonate (1 mg/ml) and 
lyophilized. The trypsin hydrolysates were filtered on im- 
munoadsorbents containing antipenicilloyl antibodies. A frac- 
tion not adsorbed under these conditions was eluted with 
0.15 M NaCl and the immunoadsorbent was washed with 
0.15 M ammonium acetate, pH 7.1, to eliminate NaCl; the 
material remaining adsorbed to the immunoadsorbent was 
eluted with 5% acetic acid and lyophilized. 
Amino acid analysis was performed on a Biotronik amino 
acid analyzer LC 5001 using the single column procedure. 
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Samples containing 5 nmol of peptides were hydrolyzed in 
vacua with 0.1 ml of 6 N HCl for 15 h at 110°C. 
The amino acid sequence of the N-terminal portions of the 
isolated tryptic peptides was determined on about 5-10 nmol of 
material by the manual 4-(dimethylamino)azobenzene 4’-iso- 
thiocyanate/phenylisothiocyanate double coupling technique. 
The resulting 4-(dimethylamino)azobenzene 4’ -isothiocyanate 
derivatives were identified on polyamide plate as described by 
Chang et al. [9]. 
Human serum albumin was labeled with N-bromoacetyl-L- 
tryptophan as indicated by Gambhir et al. [lo]. Two derivatives 
were synthesized: one containing per molecule of HSA one 
molecule of N-bromoacetyl-L-tryptophan and the other 2 
molecules. 20 mg of each derivative were added with lo3 IU of 
penicillin G in 1 ml of 0.01 M phosphate buffer, pH 7.4, con- 
taining 0.15 M NaCl and allowed to stand at 37°C for 24 h. 
After dialysis against water the mixtures were lyophihzed. 
3. RESULTS 
5 mg of either CNBr-fragment C12d-298 or 
Azw_~~~ derived from fast albumin were reduced, 
carboxymethylated and digested by trypsin. The 
hydrolysates were subjected to affinity chromatog- 
raphy on immobilized antipenicilloyl antibodies. 
The results obtained are illustrated in fig.1. This 
figure shows in both cases the emergence of a large 
peak of non-adsorbed material in 0.15 M NaCl. 
Successive washing with 5% acetic acid eluted a 
small peak of adsorbed material from the gel load- 
ed with either of the fragments. BP0 groups were 
assayed in the collected fractions by PAP inhibi- 
tion reaction using immobilized antipenicilloyl an- 
tibodies. Relative to absorbance the second peak 
contained significantly higher activity than the first 
one. The elution pattern of the first peak on 
rechromatography on the same column was similar 
to that obtained in the first chromatography run. 
The amino acid content of the material of the se- 
cond peak derived from CNBr fragment Cl&_298 
corresponded to that of a tetrapeptide containing 
1 Arg, 1 His, 1 Pro and 1 Tyr, whereas its partial 
N-terminal sequence was Arg-His-Pro. 
The amino acid content of the material of the se- 
cond peak derived from CNBr fragment A299_ 585 
corresponded to that of a pentadecapeptide con- 
taining 2 Arg, 1 His, 1 Pro, 1 Asp, 1 Tyr, 1 Ser, 
2 Val, 4 Leu, 1 Ala and 1 Lys. Its partial N- 
terminal sequence was determined as Arg-His- 
Pro-Asp. 
HSA was derivatized by treatment with N- 
bromoacetyl-L-tryptophan because this reaction 
was found to occur at histidine 146 [IO]. Binding 
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Fig. 1. Affinity chromatography on immobilized antipenicilloyl 
antibodies of a tryptic hydrolysate of (a) fragment CIZ~-298 and 
(b) fragment A299_ss5; (---) A at 280 nm; (----) % 
inhibition of the fixation of penicilloylated alkaline 
phosphatase to coated antipenicilloyl antibodies. 
capacity of untreated HSA was 2.8 x lo-* BP0 
groups per mg of protein. HSA when substituted 
with 1 mol of N-bromoacetyl-L-tryptophan per 
mol of protein fixed only 2.1 x lo-* BP0 groups 
and when substituted with 2 mol of reagent fixed 
1.7 x lo-’ BP0 groups per mg of protein. 
4. DISCUSSION 
In a previous study most BP0 groups were 
found to be located preferentially on at least two 
sites of albumin isolated from the sera of 
penicillin-treated patients. Using CNBr-peptides 
derived from albumin, one of these sites could be 
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located between Met-123 and Met-298 and the 
other between Met-298 and the C-terminal residue 
of albumin [5]. 
In an attempt to locate more precisely the fixa- 
tion sites for BP0 groups, the albumin-derived 
CNBr-fragments Cr_%_298 and A299_585 were 
degraded by trypsin and the peptides carrying BP0 
groups were isolated by immunoaffinity on im- 
mobilized antipenicilloyl antibodies. From each of 
the above fragments only one peptide was isolated. 
The amino acid composition and the partial N- 
terminal sequence of each of these peptides al- 
lowed us to allocate them to well-defined places in 
the albumin molecule by taking advantage of the 
sequence established by Behrens et al. [l I] and 
Meloun et al. [12]. The peptide derived from frag- 
ment c124-298 was identified to the tetrapeptide in- 
volving residues 145-148 and the other peptide 
derived from fragment A299_585 was identified as 
the pentadecapeptide involving residues 337-35 1. 
BP0 groups have for a long time been con- 
sidered to be the major antigenic determinants 
responsible for allergic reactions to penicillin 
[ 13- 171. These groups were supposed to react with 
proteins essentially through binding to e-amino 
groups of lysine residues 113-161. However, 
Bundgaard [ 181 and Yamana et al. [ 191 showed 
that reaction with lysine residues was very slow at 
neutral pH which is consistent with the p& of 
lysine (8.45-10.53). Since the pK, of histidine is 
equal to 7, Bundgaard [20] and Yamana et al. [21] 
were prompted to assume that BP0 groups should 
first react with histidine before reacting with 
lysine. The putative involvement of histidine in fix- 
ation of BP0 groups could be inferred from the 
report of Wagner et al. [22] who showed that car- 
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boxymethylation of albumin resulted in reduction 
of BP0 group fixation. 
The involvement of lysine residues in fixation of 
BP0 groups in our experiments can be excluded. 
In fact, lysine is lacking in the tetrapeptide. In the 
pentadecapeptide the single lysine is located at the 
C-terminal position. Substitution of this lysine by 
BP0 groups would have prevented the adjacent 
peptide bond from being cleaved. In contrast, each 
of the two peptides contains one histidine (residues 
146 and 338) which of all the constituent amino 
acids is the only one prone to reacting with BP0 
groups. In support of this it was verified that 
25-39% less BP0 groups were fixed in vitro by 
HSA labeled with N-bromoacetyl-L-tryptophan. 
The ready reactivity with BP0 groups of 
histidines 146 and 338 out of the 16 histidine 
residues present in the albumin molecule can be ac- 
counted for on the basis of their particular location 
on the polypeptide segments connecting helices of 
the large loops 1-C and 2-C (fig.2). In the struc- 
tural model by Brown [23] these polypeptides are 
located in regions rich in reactive groups. 
The two histidine residues 146 and 338 exhibit 
some structural common features. They are at near 
equidistance of disulfide bonds. On the N-terminal 
side, both are preceded by six identical amino acid 
residues (Leu-Tyr-Glu-X-Ala-Arg-Arg) and on the 
C-terminal side they are followed by a proline 
residue. In addition, the two large loops to which 
they belong exhibit 37% of homology in amino 
acid sequence. 
Unmasking of BP0 groups bound to the 
albumin molecule requires previous enzymatic 
degradation as was also the case with CNBr 
fragments C124_298 and A299-585. Moreover, in the 
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Fig.2. Schematic representation of structure of the loops of serum albumin. 
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latter instance BP0 groups were more efficiently 
exposed after disulfide bond reduction than after 
enzyme digestion [5]. Thence, it appears that the 
unavailability of BP0 groups should not be depen- 
dent upon the overall structure of the albumin 
molecule but rather upon the structure held by the 
disulfide bonds of the loop to which these sites 
belong. This suggests that BP0 groups should be 
buried within each loop once fixed to histidine 
residues. 
Fixation of BP0 groups has extensively been 
studied in in vitro experiments. It is highly pro- 
bable that a wide variety of free amino groups can 
be involved in fixation depending upon the ex- 
perimental conditions. The experiments reported 
in the present paper have aimed at defining those 
sites which under physiological conditions are 
responsible for the fixation of BP0 groups on the 
albumin of penicillin-treated patients. 
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